NeurologyWire

AbbieVie Receives Approval for Carbidopa and Levodopa Pump

From NeurologyWire

FDA has approved Duopa (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations for people with advanced Parkinson's disease. Duopa is administered using a small, portable infusion pump that delivers carbidopa and levodopa directly into the small intestine for 16 continuous hours via a procedurally-placed tube.It was appr...

Login to read story

Monday, January 19, 2015

Show last days of articles

Study Reveals Lack of Data on Opioid Drugs

From NeurologyWire

A National Institutes of Health white paper that was released January 15 finds little to no evidence for the effectiveness of opioid drugs in the tre...Full story

FDA Approves Neostigmine Methylsulfate Injection

From NeurologyWire

Fresenius Kabihas received approval from the U.S. Food and Drug Administration to market Neostigmine Methylsulfate Injection.This is the first Freseni...Full story

Friday, January 16, 2015

Study: People Can Be Convinced They Committed a Crime That N...

From NeurologyWire

Evidence from some wrongful-conviction cases suggests that suspects can be questioned in ways that lead them to falsely believe in and confess to comm...Full story

UK Again Says 'No' to Dementia Screen

From NeurologyWire

The UK National Screening Committee (UK NSC) upheld its recommendation against screening everyone aged 65 and over for dementia.Following an extensive...Full story

Phase II of Amyotrophic Lateral Sclerosis Drug Begins

From NeurologyWire

A Phase II study of the novel molecule sNN0029 to treat Amyotrophic Lateral Sclerosis (ALS) has been initiated. This safety and preliminary evidence o...Full story

Arena Releases Encouraging MS-related Results from Phase Ib ...

From NeurologyWire

Arena Pharmaceuticals has released top-line results from a Phase 1b multiple ascending dose clinical trial for APD334, an oral drug candidate that tar...Full story

MRIGlobal Wins $54 Million NIH Neurological Disorders And St...

From NeurologyWire

MRIGlobal has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the ...Full story

One In Five Adult Epilepsy Patients Have ADHD Symptoms

From NeurologyWire

A new study says that nearly one in five adult epilepsy patients reported attention deficit hyperactivity disorder (ADHD) symptoms. This is four time...Full story

Thursday, January 15, 2015

Parkinson's Therapy Moves to Phase II

From NeurologyWire

Newron Pharmaceuticals has initiated a Phase II study of its novel molecule sNN0031 in patients with Parkinsons disease (PD). The sNN0031 Phase II saf...Full story

New Study Shows Nearly One in Five Adult Epilepsy Patients H...

From NeurologyWire

A new study says nearly one in five adult epilepsy patients reported attention deficit hyperactivity disorder (ADHD) symptoms. This is four times high...Full story

Wednesday, January 14, 2015

Gene Therapy Reverses Effects Of Spinal Muscular Atrophy

From NeurologyWire

Reversing a protein deficiency through gene therapy is effective in improving and stabilizing spinal muscular atrophy (SMA), a lethal childhood disord...Full story

Passive Smoking May Increase Risk of Severe Dementia

From NeurologyWire

A study by scientists in China, the UK and USA has found a link between passive smoking and syndromes of dementia.The study of nearly 6,000 people in ...Full story

Monday, January 12, 2015

AbbieVie Receives Approval for Carbidopa and Levodopa Pump

From NeurologyWire

FDA has approved Duopa (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations for people with advanced Parkinson's diseas...Full story

FDA Approves Extended Release Levodopa-Carbidopa

From NeurologyWire

Nearly two years after it was rejected, FDA has approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment...Full story

APDA Announces New VP of Program and Services

From NeurologyWire

The American Parkinson Disease Association (APDA) announced the appointment of Robin Kornhaber as Vice President of Programs and Services.Robin joins ...Full story